NCT05518045 2026-02-04
A Study of LM-108 as Monotherapy or in Combination With Antitumor Therapies in Subjects With Advanced Solid Tumors
LaNova Medicines Limited
Phase 1/2 Active not recruiting
LaNova Medicines Limited
Ascentage Pharma Group Inc.
LaNova Medicines Limited
TJ Biopharma Co., Ltd.
Genfleet Therapeutics (Shanghai) Inc.